Convafort®
dragée tablets, OTC drugThe product is intended for traditional application in case of the below mentioned indications and its efficiency is based exclusively on long period of application and experience. Convafort® contains cardenolide glycosides of lily of the valley increasing contraction strength of cardiac muscle (positive intropic effects).
Indications for application
Convafort® is traditionally used and an adjunctive agent during initial stages of cardiac insufficiency, not requiring application of other drugs, without symptoms of circulatory stasis and in case of cardiac asthenia in elderly individuals.
How to apply Convafort®
Unless a physician prescribes otherwise, usually adults and youths over 12 years of age 1 to 2 dragée tablets 3 times a day, 15 minutes before meal.
In case of combined treatment with strophantin, the drug may be administered at 9 hours interval before and 8 hours after strophantin injection.
In case of taking higher than recommended dose of Convafort®
Lily of the valley glycosides accumulate to a very low degree, and even taken several times a day do not cause overdose symptoms. They are eliminated through kidneys. Repeated overdose of lily of the valley glycosides did not cause toxic symptoms, however, it can not be ruled out that serious overdose may lead to poisoning with cardiac glycosides.
Symptoms of poisoning with cardiac glycosides include: vomiting, vision disorders, hallucinations and cardiac rhythm disorders.
In case of accidental overdose, it is necessary to immediately contact a physician.
In case of skipping the drug dose
Do not apply a double dose in order to supplement the omitted one.
Before you apply Convafort®
Do not apply the preparation in case of the following:
- hypersensitivity to the preparation components,
- hypokaliemia (potassium deficit),
- hypercalcemia (excess of calcium in the organism)
- cardiac conductivity disorders, e.g.: ventricular tachycardia, ventricular fibrillation, atrioventricular block, etc.
Observe special care if:
There is no improvement or symptoms of cardiac insufficiency intensify, e.g.: fluid retention in the organism appears, demonstrated by leg edemas; in such cases it is necessary to consult a physician who will decide as to further treatment.
ATTENTION: If the following symptoms of serious cardiac insufficiency occur: pain in the region of heart spreading to arm, pain in the upper abdomen, pain in the neck and dyspnea – it is necessary to immediately report to a physician.
Application of the drug in children
Do not administer to children younger than 12 years of age.
Pregnancy
No controlled clinical trials have been conducted in pregnant women and for this reason it is not recommended to apply the preparation during this period.
Breast feeding
Do not apply during breast feeding period because of the possibility of cardiac glycosides penetration into mother’s milk.
Driving of vehicles and operation of moving mechanisms
No data concerning influence on the individuals driving vehicles and operating moving mechanisms.
Use of other drugs
It is necessary to inform a physician about all the recently taken drugs, even those sold without prescription.
Possible undesired effects
So far, no undesired effects have been reported in case of application according to the recommended dosage.
However, as every drug, Convafort® may cause undesired effects. In case of undesired effects, consult a physician.
Storage of Convafort®
Store at the temperature not exceeding 25 °C.
Store out of reach and sight of children.
Do not use the drug after expiry date stated on the package.
Composition
1 dragée tablet contains:
Active substance:
Dry extract of lily of the valley -15.7 mg
Auxiliary substances:
Lactose monohydrate, saccharose, talc, magnesium stearate, Arabic gum, castor oil, potato starch, celacefat
Packaging contains 30 dragée tablets
